Bladder Carcinoma Recruiting Phase 2 Trials for Avelumab (DB11945)

Also known as: Urinary bladder carcinoma / Carcinoma urinary bladder / Carcinoma of bladder / Bladder carcinoma NOS / Carcinoma bladder / Bladder neoplasms malignant / Malignant neoplasm of bladder / Bladder cancer / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0036971 (Bladder Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03324282First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder CarcinomaTreatment